a risk-adapted treatment approach for mantle cell lymphoma
Published 5 years ago • 277 plays • Length 4:31Download video MP4
Download video MP3
Similar videos
-
2:07
novel treatments for mantle cell lymphoma
-
2:09
the optimal sequencing of novel therapies in mantle cell lymphoma
-
1:24
treatment methods in mantle cell lymphoma
-
2:01
current and future therapies in mantle cell lymphoma
-
7:01
management of mantle cell lymphoma in the era of novel targeted drugs
-
2:09
recent investigational advances in mantle cell lymphoma treatment
-
3:42
early pet-adapted treatment for hodgkin lymphoma: 10-year follow-up analysis
-
5:50
venetoclax and r2 in mantle cell lymphoma
-
1:21:44
cell blocks and ihc in cytopathology
-
6:28
cytoquest™ cr ctc enrichment - rbc lysis
-
10:42
understanding mantle cell lymphoma with jia ruan, md, ph.d.
-
2:35
next questions for mantle cell lymphoma
-
1:59
prognostic markers in mcl and the value of car-t therapy in treating high-risk disease
-
2:19
determining the optimal use of targeted therapies in mantle cell lymphoma
-
3:34
effect of time to relapse on os in mcl following autohct
-
2:00
glofitamab: a valuable agent for the treatment of patients with r/r mantle cell lymphoma
-
2:41
rb/rc induction for mantle cell lymphoma: promising pooled analysis data
-
2:05
the value of mrd assessment in lymphoma
-
2:37
the changing role of autosct in mantle cell lymphoma: the impact of novel agents
-
1:15
risk stratification for ctcl
-
1:33
zamtocabtagene autoleucel for the treatment of patients with r/r dlbcl
-
1:15
clinical impact of atm and tp53 mutations in mantle cell lymphoma